Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human NFYA Antibodies:
anti-Mouse (Murine) NFYA Antibodies:
anti-Rat (Rattus) NFYA Antibodies:
Go to our pre-filtered search.
Results from a study on gene expression variability markers in early-stage human embryos shows that NFYA is a putative expression variability marker for the 3-day, 8-cell embryo stage.
Suggest NF-YAs and lamin A (show LMNA Antibodies) expression levels as novel potential biomarkers useful to identify G1 endometrial carcinoma patients with risk of recurrence.
increased expression of NF-YA may promote a malignant phenotype in OS cells via modulation of FASN (show FASN Antibodies) expression.
The findings indicate that overexpression of NF-YA contributes to tumor angiogenesis through EZH2 (show EZH2 Antibodies)-STAT3 (show STAT3 Antibodies) signaling in human melanoma cells, highlighting NF-YA as a potential therapeutic target in human melanoma.
Data indicate that specific cancer-driving nodes are generally under NF-YA/B control.
our results indicate that NF-YA alternative splicing is an influential muscle cell determinant, through direct regulation of selected cell cycle blocking genes, and, directly and indirectly, of muscle-specific (show EIF3K Antibodies) transcription factors
enhanced CDCA8 (show CDCA8 Antibodies) promoter activities by NF-Y overexpression and reduced CDCA8 (show CDCA8 Antibodies) transcription by NF-Y knockdown further verified that NF-Y is a positive regulator of CDCA8 (show CDCA8 Antibodies) transcription.
Data show that Zinc-fingers and homeoboxes 2 (ZHX2 (show ZHX2 Antibodies)) represses nuclear transcription factor Y alpha (NF-Y)-mediated activation of multidrug resistance 1 (MDR1 (show TBC1D9 Antibodies)) transcription.
NF-Y inhibits NT2/D1 cell growth in p53 (show TP53 Antibodies)-independent manner and decreases SOX2 (show SOX2 Antibodies) expression.
Stimulation of the lymphocytes with phytohemagglutinin, restores normal OGG1 (show OGG1 Antibodies) levels and repair rates. MAP kinase (show MAPK1 Antibodies) c-Jun N-terminal kinase (JNK) and the recruitment of the transcription factor NFYA to the promoter region of OGG1 (show OGG1 Antibodies) are shown to be involved.
Interaction of C/EBP-beta (show CEBPB Antibodies) and NF-Y factors constrains activity levels of the nutritionally controlled promoter IA expressing the acetyl-CoA carboxylase-alpha (show ACACA Antibodies) gene in cattle.
Data show that nuclear factor Y (NF-Y) binds to the inverted CCAAT element (ICE) in the Fatty acid synthase (Fasn (show FASN Antibodies)) promoter specifically in refeeding states.
findings may point to a possible role of NF-YA in stress conditions that occur in chronic obesity, ER stress might be involved in the pathogenesis of obesity through NF-YA depletion.
we conclude that NF-Y and YY1 (show YY1 Antibodies) are important for the basal transcription of Pcyt2 (show PCYT2 Antibodies) and that NF-Y is involved in the inhibitory effects of 25-HC on Pcyt2 (show PCYT2 Antibodies) transcription.
these results indicate that the transcription factor NF-Y regulates the proximal promoter activity of mouse Col11a1 (show COL11A1 Antibodies) gene in chondrocytes
these results raise an exciting possibility that targeting CDK1 (show CDK1 Antibodies) or NF-Y in the diseased heart may inhibit fibrosis and subsequently confer cardioprotection.
NF-Ya is a functional activator of Bmal1 (show ARNTL Antibodies) transcription and it cooperates with Sp1 (show SP1 Antibodies) and Rev-Erbalpha (show NR1D1 Antibodies) to generate the daily cycle of Bmal1 (show ARNTL Antibodies) expression.
Sp1 (show SP1 Antibodies), CREB (show CREB1 Antibodies), HNF-1 (show HNF1A Antibodies), and NF-Y, known to be responsive to hormones and diet, regulate NAGS (show NAGS Antibodies) transcription
results indicate nuclear transcription factor NF-Y as a pivotal upstream participant in a regulatory network necessary for the preservation of cycling hematopoietic stem cell.
Findings establish that NF-Y acts upstream of E2F1 (show E2F1 Antibodies) in p53 (show TP53 Antibodies)-mediated apoptosis.
Transcriptional regulation of myeloid differentiation primary response (MyD) genes during myeloid differentiation is mediated by nuclear factor Y.
The protein encoded by this gene is one subunit of a trimeric complex, forming a highly conserved transcription factor that binds to CCAAT motifs in the promoter regions in a variety of genes. Subunit A associates with a tight dimer composed of the B and C subunits, resulting in a trimer that binds to DNA with high specificity and affinity. The sequence specific interactions of the complex are made by the A subunit, suggesting a role as the regulatory subunit. In addition, there is evidence of post-transcriptional regulation in this gene product, either by protein degradation or control of translation. Further regulation is represented by alternative splicing in the glutamine-rich activation domain, with clear tissue-specific preferences for the two isoforms.
, nuclear transcription factor Y, alpha
, CAAT box DNA-binding protein subunit A
, CAAT-box DNA binding protein subunit A
, CCAAT-binding transcription factor subunit B
, HAP2 CCAAT-binding protein
, Transcription factor NF-Y, A subunit
, nuclear transcription factor Y subunit A
, nuclear transcription factor Y subunit alpha
, CAAT-box DNA-binding protein subunit A
, NF-Y protein chain A
, nuclear transcription factor-Y alpha